Bone marrow derived mesenchymal stem cells pretreated with erythropoietin accelerate the repair of acute kidney injury

Abstract Background Mesenchymal stem cells (MSCs) represent a promising treatment option for acute kidney injury (AKI). The main drawbacks of MSCs therapy, including the lack of specific homing after systemic infusion and early cell death in the inflammatory microenvironment, directly affect the the...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Song Zhou, Yu-ming Qiao, Yong-guang Liu, Ding Liu, Jian-min Hu, Jun Liao, Min Li, Ying Guo, Li-pei Fan, Liu-Yang Li, Ming Zhao
Формат: Artigo
Язык:Inglês
Опубликовано: BMC 2020-11-01
Серии:Cell & Bioscience
Предметы:
Acute kidney injury
Bone marrow derived mesenchymal stem cells
Erythropoietin
Lung entrapment
SIRT1
Online-ссылка:http://link.springer.com/article/10.1186/s13578-020-00492-2
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы